Technical Analysis for ARPO - Aerpio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 1.2 0.00% 0.00
ARPO closed unchanged on Friday, April 16, 2021, on 31 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ARPO trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish -4.00%
Narrow Range Bar Range Contraction -4.00%
NR7 Range Contraction -4.00%
Inside Day Range Contraction -4.00%
Older End-of-Day Signals for ARPO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 10 hours ago
Down 3% about 16 hours ago
Down 2 % about 16 hours ago
Down 1% about 16 hours ago
Fell Below Previous Day's Low about 16 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aerpio Pharmaceuticals, Inc. Description

Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for ocular diseases. The company's lead product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company is headquartered in Cincinnati, Ohio. Aerpio Pharmaceuticals, Inc. operates independently of Akebia Therapeutics, Inc. as of December 22, 2011.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Clinical Development Pharmacy Monoclonal Antibody Monoclonal Antibodies Inflammatory Bowel Disease Diabetic Retinopathy Retinopathy Treatment Of Inflammatory Bowel Disease Hypoxia Inducible Factors Ocular Disease Ocular Diseases Tie2

Is ARPO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.31
52 Week Low 0.565
Average Volume 1,742,455
200-Day Moving Average 1.44
50-Day Moving Average 1.60
20-Day Moving Average 1.38
10-Day Moving Average 1.28
Average True Range 0.11
ADX 13.45
+DI 17.48
-DI 28.40
Chandelier Exit (Long, 3 ATRs ) 1.77
Chandelier Exit (Short, 3 ATRs ) 1.47
Upper Bollinger Band 1.68
Lower Bollinger Band 1.08
Percent B (%b) 0.2
BandWidth 43.90
MACD Line -0.10
MACD Signal Line -0.09
MACD Histogram -0.0105
Fundamentals Value
Market Cap 56.53 Million
Num Shares 47.1 Million
EPS -0.28
Price-to-Earnings (P/E) Ratio -4.36
Price-to-Sales 4.81
Price-to-Book 1.74
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.28
Resistance 3 (R3) 1.27 1.23 1.26
Resistance 2 (R2) 1.23 1.21 1.24 1.26
Resistance 1 (R1) 1.22 1.20 1.23 1.23 1.25
Pivot Point 1.18 1.18 1.19 1.19 1.18
Support 1 (S1) 1.17 1.16 1.18 1.18 1.15
Support 2 (S2) 1.13 1.15 1.14 1.14
Support 3 (S3) 1.12 1.13 1.14
Support 4 (S4) 1.13